glp 1 drugs novo nordisk The FDA has approved the first pill version of GLP-1 drugs. says participants who took the Wegovy pill in clinical trials lost an average of 16.6% of their body weight Novo Nordisk said on Tuesday

It is prescribed as a subcutaneous pen-injector

This is especially helpful for patients with type 2 diabetes or those at risk of developing diabetes

Semaglutide, delayed gastric emptying, and intraoperative pulmonary aspiration: a case report (Semaglutide, vidange gastrigue retardee et aspiration pulmonaire peroperatoire: une presentation de case)

10.1073/pnas.0230620100 [DOI] [PMC free article] [PubMed] [Google Scholar] 26.Gorrell MD

Following the 12 wk protocol, animals were used for tolerance tests and sacrificed for tissue extraction for further analysis (outlined below)

The results of this meta-analysis suggest that GLP-1 therapy has a significant impact on the incidence of death from cardiovascular causes and fatal or non-fatal stroke in T2DM patients